共 64 条
[1]
Whitlock RP(2012)Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest. 141 e576S-e600S
[2]
Sun JC(2007)Acute coronary syndrome in infective endocarditis Rev Esp Cardiol 60 24-31
[3]
Fremes SE(2014)Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI)[J] BMC Infect Dis 14 230-75
[4]
Rubens FD(2005)Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study[J] Circulation 112 69-316
[5]
Teoh KH(2003)Risk factors for “major” embolic events in hospitalized patients with infective endocarditis[J] Am Heart J 146 311-1392
[6]
Manzano MC(2013)Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort[J] J Am Coll Cardiol 62 1384-1495
[7]
Vilacosta I(2002)Risk of embolization after institution of antibiotic therapy for infective endocarditis[J] J Am Coll Cardiol 39 1489-140
[8]
San RJ(1997)Effect of antibiotic treatment on vegetation size and complication rate in infective endocarditis[J] Clin Cardiol 20 132-358
[9]
Aragoncillo P(1985)Penetration of beta-lactam antibiotics into cardiac vegetations, aorta and heart muscle in experimental Staphylococcus aureus endocarditis: comparison of ceftazidime, cefuroxime and methicillin J Antimicrob Chemother. 16 349-427
[10]
Sarria C(1982)Penetration of antibiotics into vegetation of heart valves: a mathematical model Chemotherapy. 28 421-652